- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02802085
VEGA Prospective Kiel
January 22, 2019 updated by: Aesculap AG
A Prospective Observational 5 Year Follow-up on a Historical Consecutive Cohort of 100 Primary Total Knee Arthroplasty (TKA) Cases Treated With the Posterior-stabilized VEGA System® PS
Voluntary Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation.
For this PMCF only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been or are to be carried out (acc. to MPG §23b).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This non-interventional clinical study (NIS) is conducted to clinically confirm the safety and performance of the Aesculap® VEGA System® PS components under routine conditions.
The VEGA System® PS is an established TKA design, and there is a long-lasting experience in the use of PS components in particular; thus a NIS is thought to be sufficient to give the required confirmation.
For this NIS only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been and are to be carried out (acc. to MPG §23b).
This voluntary NIS is part of the post-marketing surveillance for the product under investigation.
Study Type
Observational
Enrollment (Actual)
84
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kiel, Germany, 24119
- MEDBALTIC GmbH c/o Mare Klinikum
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
adult patients
Description
Inclusion Criteria:
- Patient has received primary TKA at the study site five to six years ago using the product under investigation because of the following severe knee joint conditions that could not be treated through other therapies:
- degenerative osteoarthritis,
- rheumatoid arthritis,
- posttraumatic arthritis,
- symptomatic knee instability, knee stiffness or deformation of the knee joint
- Age at the time of surgery ≥ 18 years
- Patient signed informed consent
Exclusion Criteria:
- Age younger than 18 years at the time of surgery
- Any prior joint replacement at the index knee
- Patient did not sign informed consent
- All cases not listed under indications (according to IfU)
- All cases showing any contraindication (according to IfU)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Knee Arthroplasty
Vega Knee Arthroplasty
|
TKA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Revision (non-survival) rate
Time Frame: 5 years
|
The objective of the study is to collect clinical 5 year outcome information on the product under investigation when used in routine clinical practice.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: 5 years
|
Changes of the total Knee injury and Osteoarthritis Outcome Score (KOOS) from the preoperative baseline to the 5 year postoperative assessment
|
5 years
|
Physical Component Summary (PCS-12) of SF-12® Health Survey (SF-12)
Time Frame: 5 years
|
Changes of the total SF-12® Health Survey (SF-12) from the preoperative baseline to the 5 year postoperative assessment
|
5 years
|
Mental Component Summary (MCS-12) of SF-12® Health Survey (SF-12)
Time Frame: 5 years
|
Changes of the total SF-12® Health Survey (SF-12) from the preoperative baseline to the 5 year postoperative assessment
|
5 years
|
Pain
Time Frame: 5 years
|
Changes of anterior knee pain according to the Waters and Bentley rating system from the preoperative baseline to the 5 year postoperative assessment
|
5 years
|
Knee Score (KS) of Knee Society Score (KSS)
Time Frame: 5 years
|
The Knee Score (KS) of the Knee Society Score (KSS) at the 5 year postoperative assessment
|
5 years
|
Functional Score (FS) of Knee Society Score (KSS)
Time Frame: 5 years
|
The Functional Score (FS) of the Knee Society Score (KSS) at the 5 year postoperative assessment
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ludger Gerdesmeyer, Professor, orthopedics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
February 1, 2018
Study Completion (Actual)
February 1, 2018
Study Registration Dates
First Submitted
May 25, 2016
First Submitted That Met QC Criteria
June 15, 2016
First Posted (Estimate)
June 16, 2016
Study Record Updates
Last Update Posted (Actual)
January 23, 2019
Last Update Submitted That Met QC Criteria
January 22, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAG-I-H-1319
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Universidad Autonoma de Nuevo LeonCompletedRheumatoId ArthritisMexico
-
Hamad Medical CorporationUnknownRHEUMATOID ARTHRITISQatar
Clinical Trials on VEGA Knee
-
BBraun Medical SASRecruiting
-
McMaster UniversityAtlas Institute for Veterans and FamiliesRecruitingDomestic Violence | Veterans | Child Maltreatment | Veterans FamilyCanada
-
McMaster UniversityRoyal College of Physicians and Surgeons of CanadaActive, not recruitingPediatric ALL | Domestic Violence | Child Maltreatment | Psychiatry | Education, Medical, GraduateCanada
-
Atos Medical ABPeking Union Medical College Hospital; Beijing Tongren Hospital; Eye & ENT Hospital...Active, not recruitingLaryngectomy; StatusChina
-
Atos Medical ABThe Netherlands Cancer InstituteCompleted
-
Atos Medical ABThe Netherlands Cancer InstituteTerminatedTotal LaryngectomyNetherlands
-
Center for Sight, Sacramento, CANot yet recruitingKeratoconus | EctasiaUnited States
-
University of WashingtonÖssur EhfCompletedTransfemoral AmputationUnited States
-
OPUM Technologies US LTDShirley Ryan AbilityLabRecruiting
-
Zimmer BiometCompleted